Unibest 优贝德
← Back to patent-cliff list

奥吡卡朋

Tier C — Watch / trade

Opicapone

Bial-Portela
Originator
2016
First approval
-
Expiry (public)
$0.05B ▲
Peak sales
化学药
Type

TargetsCOMT

Brand欧捷能、Ongentys

Indications (approved)帕金森病、帕金森综合征

Regional status

US
批准上市
2020-04-24
EU
批准上市
2016-06-24
China
申请上市
2021-03-10
Japan
批准上市
2020-06-29

Synthetic routes & intermediates2 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 1

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 7 · Total yield 0.172 g
Synthetic routes & intermediates Route 1
CodeCAS No.Intermediate
OPIC-001121-34-6Available4-hydroxy-3-methoxybenzoic acid
OPIC-00215785-54-34-hydroxy-3-methoxy-5-nitrobenzoic acid
OPIC-00384211-30-33,4-dihydroxy-5-nitrobenzoic acid
OPIC-004923288-55-53,4-bis(benzyloxy)-5-nitrobenzoic acid
OPIC-005896125-90-9(Z)-2,5-dichloro-N'-hydroxy-4,6-dimethylnicotinimidamide
OPIC-0061229803-77-3(Z)-N'-((3,4-bis(benzyloxy)-5-nitrobenzoyl)oxy)-2,5-dichloro-4,6-dimethylnicotinimidamide
OPIC-0071044136-99-35-(3,4-bis(benzyloxy)-5-nitrophenyl)-3-(2,5-dichloro-4,6-dimethylpyridin-3-yl)-1,2,4-oxadiazole
OPIC-0081044137-00-93-(5-(3,4-bis(benzyloxy)-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-2,5-dichloro-4,6-dimethylpyridine 1-oxide
ProcessRoute 2Steps 9 · Total yield 13.6 kg
Synthetic routes & intermediates Route 2
CodeCAS No.Intermediate
OPIC-001121-34-6Available4-hydroxy-3-methoxybenzoic acid
OPIC-00215785-54-34-hydroxy-3-methoxy-5-nitrobenzoic acid
OPIC-005896125-90-9(Z)-2,5-dichloro-N'-hydroxy-4,6-dimethylnicotinimidamide
OPIC-009123-54-6pentane-2,4-dione
OPIC-010107-91-52-cyanoacetamide
OPIC-011769-28-84,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile
OPIC-01223819-92-35-chloro-4,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile
OPIC-01391591-63-82,5-dichloro-4,6-dimethylnicotinonitrile
OPIC-0141443319-15-04-hydroxy-3-methoxy-5-nitrobenzoyl chloride
OPIC-0151391712-50-74-(3-(2,5-dichloro-4,6-dimethylpyridin-3-yl)-1,2,4-oxadiazol-5-yl)-2-methoxy-6-nitrophenol
OPIC-0161402714-41-32,5-dichloro-3-(5-(4-hydroxy-3-methoxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine 1-oxide

Frequently asked questions

What are the approved indications of Opicapone?

Approved indications include: 帕金森病, 帕金森综合征.

When does the Opicapone patent expire?

No public expiry year is available for Opicapone yet; this page updates once verified.

How many synthesis routes are recorded for Opicapone?

2 synthesis routes are recorded; the shortest is 7 steps with 0.172 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Opicapone intermediates?

1 intermediate CAS of Opicapone are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Opicapone intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-24